ScieGen Pharmaceuticals Inc drugs
5 results
Benztropine mesylate (benztropine mesylate)
(Benztropine Mesylate)ScieGen Pharmaceuticals Inc
Usage: Benztropine mesylate is indicated as an adjunct treatment for all forms of parkinsonism and for controlling extrapyramidal disorders (excluding tardive dyskinesia) caused by neuroleptic medications such as phenothiazines.
Ethacrynic acid (ethacrynic acid)
(Ethacrynic Acid)ScieGen Pharmaceuticals Inc
Usage: Ethacrynic Acid Tablets are indicated for treating edema when stronger diuretics are needed, including conditions like congestive heart failure, liver cirrhosis, renal disease, and short-term management of ascites, idiopathic edema, lymphedema, and in pediatric patients with congenital heart disease or nephrotic syndrome.
Hydrochlorothiazide (hydrochlorothiazide)
(Hydrochlorothiazide)ScieGen Pharmaceuticals Inc
Usage: Hydrochlorothiazide capsules are indicated for managing hypertension, used alone or with other antihypertensives. They are suitable for patients at risk of hyperkalemia, including those on ACE inhibitors. In pregnancy, diuretics should only be used for pathologic edema, not for physiological fluid retention.
Nabumetone (nabumetone)
(Nabumetone)ScieGen Pharmaceuticals Inc
Usage: Nabumetone tablets are indicated for the relief of signs and symptoms associated with osteoarthritis and rheumatoid arthritis. It is important to use the lowest effective dose for the shortest duration necessary, considering individual patient treatment goals and potential risks.
Raloxifene hydrochloride (raloxifene hydrochloride)
(Raloxifene hydrochloride)ScieGen Pharmaceuticals Inc
Usage: Raloxifene hydrochloride tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women, and for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk of breast cancer. Regular breast exams and mammograms are recommended during treatment.